Egetis Therapeutics AB: European Commission approves Egetis' Emcitate (tiratricol) as the first and only treatment for patients with MCT8 deficiency
Egetis Therapeutics AB (publ) ("Egetis" or the "Company") (Nasdaq Stockholm: EGTX), today announced that the European Commission (EC) has approved Emcitate® (tiratricol) ...
moneycontrol.com3d
Company History - Procter & Gamble Health
1967 - The Company was incorporated on 26th April, as a private limited company. It was converted into a public limited company on 29th June, 1981. Among the important items manufactured by the ...
pharmaphorum5d
Managing the challenges and embracing the opportunities of EU-wide HTA
It will become mandatory for advanced therapeutic medicinal products and oncology products in January 2025, for orphan drugs by January 2028, and for all other products by January 2030.
pharmaphorum3d
Syncona to acquire struggling AGTC for $23.5 million
It has been granted FDA orphan drug designation and European Commission orphan medicinal product designation ... certain milestones related to AGTC’s products. Chief investment officer of ...
HUB4d
Committee imagines a new future for immunology research at Johns Hopkins
Johns Hopkins University has established a Planning Committee for Immunology, a first step toward creating a new interdivisional entity to advance research in the field. Immunology is a branch of ...
Roll Call3d
‘Constitutional duty’: House chairs make case for more committee operations funding
House committee chairs are asking for millions of dollars more for internal operations this Congress, despite a push to shrink the federal budget and make way for a series of expensive priorities ...
News Medical on MSN4d
Ariceum Therapeutics receives FDA’s Orphan Drug Designation for targeted radionuclide cancer treatment
Ariceum Therapeutics (Ariceum), a private biotech company developing radiopharmaceutical products for the diagnosis and treatment of certain hard-to-treat cancers, today announced that the U.S. Food ...
Business Wire4d
Omeros Corporation Announces Upcoming Presentations Detailing Outcomes of Narsoplimab Treatment for TA-TMA Under an Expanded Access Program
Omeros Corporation (Nasdaq: OMER) today announced two presentations that will be featured at the 2025 Tandem Meetings – the ...
Acsh.org3d
Rare Diseases Are Neglected. The FDA Needs A Dedicated 'Center of Excellence for Rare Diseases'.
The FDA has made some modest efforts, but it needs an internal organization that understands and would be an aggressive ...
consilium.europa3d
Committee for Civilian Aspects of Crisis Management (CivCom)
We use cookies in order to ensure that you can get the best browsing experience possible on the Council website. Certain cookies are used to obtain aggregated statistics about website visits to help ...
Radio Pakistan4d
Ruet-e-Hilal committee to meet tomorrow for Ramadan moon
A meeting of the Central Ruet-e-Hilal Committee will be held in Peshawar on Monday for sighting the crescent of Ramazan in the country. Chairman of the Central Ruet-e-Hilal Committee Maulana Syed ...
Nature1d
Natural products articles from across Nature Portfolio
Natural products are small molecules produced naturally by any organism including primary and secondary metabolites. They include very small molecules, such as urea, and complex structures ...